Navigation Links
SuperNova Diagnostics® Selected to Present at Launch: Silicon Valley 2011
Date:5/25/2011

WASHINGTON, LONDON and HONG KONG, May 25, 2011 /PRNewswire/ -- SuperNova Diagnostics®, Inc., a privately-held global diagnostics company for human and non-human health applications, today announced it has been selected to present at The Silicon Valley Association of Startup Entrepreneurs (SVASE) annual Launch: Silicon Valley 2011 at Microsoft's Mountain View, California campus on Tuesday, June 7, 2011 at 1:15 p.m. PDT.  The presentation will include an overview of SuperNova's proprietary point-of-care (POC) and point-of-use (POU) diagnostic technology targeting four industry sectors: human health, animal health, industrial and biodefence/biosecurity.

"We are honored to be selected as one of 30 innovative companies chosen from more than 300 applicants to present at Launch: Silicon Valley 2011," said Neil J. Campbell, president and CEO of SuperNova Diagnostics.  "This recognition is an example of the dedication of the SuperNova team."

Launch: Silicon Valley 2011 will feature emerging companies in the fields of information technology, mobility, digital media, next generational Internet, life sciences and clean tech.  

About SuperNova Diagnostics®, Inc.

SuperNova® is a development-stage diagnostics company with a proprietary platform for conducting diagnostics at the site of interest with point-of-care in human health and point-of-use for non-human health applications.  A powerful proprietary nanochemistry, AmpCrystal®, can deliver novel, next generation performance for pathogens, proteins, and directly measure DNA without PCR with ultra-low sensitivity and specificity while not sacrificing a dynamic range of measurements.  SuperNova can be utilized in a wide range of diagnostic formats (lateral flow, self-contained cartridges, microtitre, microarrays, closed systems, research products and OEM). SuperNova® — Putting the Laboratory in the Palm of Your Hand®.  For additional information, please visit www.supernovadiagnostics.com.

About The Silicon Valley Association of Startup Entrepreneurs (SVASE)

Founded in 1995 by entrepreneurs, for entrepreneurs, The Silicon Valley Association of Startup Entrepreneurs (SVASE) is the largest and fastest growing nonprofit in Northern California dedicated exclusively to helping technology and life science entrepreneurs start and grow successful businesses.

SVASE provides support and resources for entrepreneurs, from the idea through initial rounds of funding to product launch, delivered at 12 monthly events and a continually evolving web site.  For more information about SVASE, please visit www.svase.org.

For more information on Launch: Silicon Valley 2011, please visit http://www.launchsiliconvalley.org.

Media Contacts:
Tiberend Strategic Advisors, Inc.
(212) 827-0020
Farrell Denby, fdenby@tiberend.com
or
Madeleine Desmond, mdesmond@tiberend.com


'/>"/>
SOURCE SuperNova Diagnostics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. SuperNova Diagnostics® Announces Agreement with KSB Diagnostics of China to Commercialise Neopterin Diagnostics
2. Quest Diagnostics® Care360™ EHR Receives ONC-ATCB 2011/2012 Certification
3. Conflict of Interest Management System Selected by Henry Ford Health System
4. Honeywells Envergent Technologies Selected by Malaysian Company for Renewable Energy Project
5. RRD Selected as Development Partner for NIH Therapeutics for Rare and Neglected Diseases Program
6. Angiotech Pharmaceuticals, Inc. Releases Selected Projected Financial Information
7. CSA Medical Selected to Present at Mid-Atlantic Bio Conference
8. PMC BioTec Selected as a GoingGreen Silicon Valley 100 Winner
9. PROLOR Biotechs Longer-Acting Human Growth Hormone Data Selected for Presentation at 5th International Congress Of The Growth Hormone Research Society and IGF Society
10. Honeywell UOP Technology Selected to Support Conversion of Biomass to Fuel at California Renewable Energy Facility
11. Ion Torrent Selected as World Economic Forum Technology Pioneer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... -- Liquid Biotech USA , Inc. ... Research Agreement with The University of Pennsylvania ("PENN") ... patients.  The funding will be used to assess ... outcomes in cancer patients undergoing a variety of ... to support the design of a therapeutic, decision-making ...
(Date:6/24/2016)... , ... June 24, 2016 , ... While the majority ... as the Cary 5000 and the 6000i models are higher end machines that use ... height of the spectrophotometer’s light beam from the bottom of the cuvette holder. ...
(Date:6/23/2016)... 2016   Boston Biomedical , an industry ... to target cancer stemness pathways, announced that its ... Drug Designation from the U.S. Food and Drug ... including gastroesophageal junction (GEJ) cancer. Napabucasin is an ... cancer stemness pathways by targeting STAT3, and is ...
(Date:6/23/2016)... MA (PRWEB) , ... June 23, 2016 , ... ... Peel Plate® YM (Yeast and Mold) microbial test has received AOAC Research Institute ... platform of microbial tests introduced last year,” stated Bob Salter, Vice President of ...
Breaking Biology Technology:
(Date:6/22/2016)... ANGELES , June 22, 2016 /PRNewswire/ ... identity management and verification solutions, has partnered ... edge software solutions for Visitor Management, Self-Service ... provides products that add functional enhancements ... partnership provides corporations and venues with an ...
(Date:6/16/2016)... , June 16, 2016 ... size is expected to reach USD 1.83 billion ... Grand View Research, Inc. Technological proliferation and increasing ... applications are expected to drive the market growth. ... , The development of advanced multimodal ...
(Date:6/7/2016)...  Syngrafii Inc. and San Antonio Credit Union ... integrating Syngrafii,s patented LongPen™ eSignature "Wet" solution into ... result in greater convenience for SACU members and ... existing document workflow and compliance requirements. ... Highlights: ...
Breaking Biology News(10 mins):